Literature DB >> 23791042

Distance traveled and frequency of interstate opioid dispensing in opioid shoppers and nonshoppers.

M Soledad Cepeda1, Daniel Fife, Yingli Yuan, Greg Mastrogiovanni.   

Abstract

UNLABELLED: Little is known about how far opioid shoppers travel or how often they cross state lines to fill their opioid prescriptions. This retrospective cohort study evaluated these measures for opioid shoppers and nonshoppers using a large U.S. prescription database. Patients with ≥3 opioid dispensings were followed for 18 months. A subject was considered a shopper when he or she filled overlapping opioid prescriptions written by >1 prescriber at ≥3 pharmacies. A heavy shopper had ≥5 shopping episodes. Outcomes assessed were distance traveled among pharmacies and number of states visited to fill opioid prescriptions. A total of 10,910,451 subjects were included; .7% developed any shopping behavior and their prescriptions accounted for 8.6% of all opioid dispensings. Shoppers and heavy shoppers were younger than the nonshoppers. Shoppers traveled a median of 83.8 miles, heavy shoppers 199.5 miles, and nonshoppers 0 miles. Almost 20% of shoppers or heavy shoppers, but only 4% of nonshoppers, visited >1 state. Shoppers traveled greater distances and more often crossed state borders to fill opioid prescriptions than nonshoppers, and their dispensings accounted for a disproportionate number of opioid dispensings. Sharing of data among prescription-monitoring programs will likely strengthen those programs and may decrease shopping behavior. PERSPECTIVE: This study shows that opioid shoppers travel greater distances and more often cross state borders to fill opioid prescriptions than nonshoppers, and their dispensings accounted for a disproportionate number of opioid dispensings. The findings support the need for data sharing among prescription-monitoring programs to deter opioid shopping behavior.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Opioids; doctor shopping; opioid abuse; opioid diversion; prescription-monitoring programs

Mesh:

Substances:

Year:  2013        PMID: 23791042     DOI: 10.1016/j.jpain.2013.04.014

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  16 in total

Review 1.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

2.  The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers ("doctor shopping").

Authors:  Douglas C McDonald; Kenneth E Carlson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-08-11       Impact factor: 2.890

3.  Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines.

Authors:  Mei-Sing Ong; Karen L Olson; Aurel Cami; Chunfu Liu; Fang Tian; Nandini Selvam; Kenneth D Mandl
Journal:  J Gen Intern Med       Date:  2015-07-18       Impact factor: 5.128

4.  Tie Decay and Dissolution: Contentious Prescribing Practices in the Prescription Drug Epidemic.

Authors:  Victoria Shu Zhang; Marissa D King
Journal:  Organ Sci (Linthicum)       Date:  2021-01-20

5.  The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia.

Authors:  Louisa Degenhardt; Bianca Blanch; Natasa Gisev; Briony Larance; Sallie Pearson
Journal:  BMJ Open       Date:  2015-01-28       Impact factor: 2.692

6.  Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database.

Authors:  M Soledad Cepeda; Daniel Fife; Joris Berwaerts; Yingli Yuan; Greg Mastrogiovanni
Journal:  Drugs R D       Date:  2014-09

7.  Doctor shopping for medications used in the treatment of attention deficit hyperactivity disorder: shoppers often pay in cash and cross state lines.

Authors:  M Soledad Cepeda; Daniel Fife; Joris Berwaerts; Andrew Friedman; Yingli Yuan; Greg Mastrogiovanni
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-10       Impact factor: 3.829

8.  Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol.

Authors:  Natasa Gisev; Sallie-Anne Pearson; Timothy Dobbins; David C Currow; Fiona Blyth; Sarah Larney; Adrian Dunlop; Richard P Mattick; Andrew Wilson; Louisa Degenhardt
Journal:  BMJ Open       Date:  2018-12-04       Impact factor: 2.692

9.  New means, new measures: assessing prescription drug-seeking indicators over 10 years of the opioid epidemic.

Authors:  Brea L Perry; Meltem Odabaş; Kai-Cheng Yang; Byungkyu Lee; Patrick Kaminski; Brian Aronson; Yong-Yeol Ahn; Carrie B Oser; Patricia R Freeman; Jeffrey C Talbert
Journal:  Addiction       Date:  2021-07-27       Impact factor: 6.526

10.  Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.

Authors:  M Soledad Cepeda; Daniel Fife; Mary A Kihm; Greg Mastrogiovanni; Yingli Yuan
Journal:  Clin J Pain       Date:  2014-12       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.